Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review

Overview

Journal JCO Glob Oncol

Specialty Oncology

Date 2021 Mar 3

PMID 33656910

Citations 15

Authors

Rafael Leite Pacheco

Ana Luiza Cabrera Martimbianco

Felipe Roitberg

Andre Ilbawi

Rachel Riera

Affiliations

Soon will be listed here.

Abstract

Purpose: Delays and disruptions in health systems because of the COVID-19 pandemic were identified by a previous systematic review from our group. For improving the knowledge about the pandemic consequences for cancer care, this article aims to identify the effects of mitigation strategies developed to reduce the impact of such delays and disruptions.

Methods: Systematic review with a comprehensive search including formal databases, cancer and COVID-19 data sources, gray literature, and manual search. We considered clinical trials, observational longitudinal studies, cross-sectional studies, before-and-after studies, case series, and case studies. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the included studies was assessed by specific tools. The mitigation strategies identified were described in detail and their effects were summarized narratively.

Results: Of 6,692 references reviewed, 28 were deemed eligible, and 9 studies with low to moderate methodological quality were included. Five multiple strategies and four single strategies were reported, and the possible effects of mitigating delays and disruptions in cancer care because of COVID-19 are inconsistent. The only comparative study reported a 48.7% reduction observed in the number of outpatient visits to the hospital accompanied by a small reduction in imaging and an improvement in radiation treatments after the implementation of a multiple organizational strategy.

Conclusion: The findings emphasize the infrequency of measuring and reporting mitigation strategies that specifically address patients' outcomes and thus a scarcity of high-quality evidence to inform program development. This review reinforces the need of adopting standardized measurement methods to monitor the impact of the mitigation strategies proposed to reduce the effects of delays and disruptions in cancer health care because of COVID-19.

Citing Articles

A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.

Dunn M, Li D, Emerson M, Thompson C, Nichols H, Van Alsten S PLoS Med. 2024; 21(12):e1004500.

PMID: 39621782 PMC: 11649116. DOI: 10.1371/journal.pmed.1004500.

The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.

Cioffi G, Waite K, Price M, Neff C, Kruchko C, Ostrom Q Neuro Oncol. 2024; 26(4):764-774.

PMID: 38167948 PMC: 10995517. DOI: 10.1093/neuonc/noad235.

COVID-19 or Cancer Stress? Anxiety and Depressive Symptoms in Patients with Advanced Lung Cancer.

Blevins T, Lo S, Coker C, Arrato N, Reisinger S, Shields P Int J Behav Med. 2023; 31(2):325-330.

PMID: 37594667 PMC: 11271711. DOI: 10.1007/s12529-023-10206-w.

An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs.

Muka T, Li J, Farahani S, Ioannidis J Elife. 2023; 12.

PMID: 37014058 PMC: 10156163. DOI: 10.7554/eLife.85679.

Impact of facilitating continued accessibility to cancer care during COVID-19 lockdown on perceived wellbeing of cancer patients at a rural cancer center in Rwanda.

Niyigena A, Cubaka V, Uwamahoro P, Mutsinzi R, Uwizeye B, Mukamasabo B PLOS Glob Public Health. 2023; 3(2):e0001534.

PMID: 36963043 PMC: 10021873. DOI: 10.1371/journal.pgph.0001534.

References

Al-Rashdan A, Roumeliotis M, Quirk S, Grendarova P, Phan T, Cao J . Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations. Adv Radiat Oncol. 2020; 5(4):575-576. PMC: 7194663. DOI: 10.1016/j.adro.2020.03.011. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Montesi G, Di Biase S, Chierchini S, Pavanato G, Virdis G, Contato E . Radiotherapy during COVID-19 pandemic. How to create a No fly zone: a Northern Italy experience. Radiol Med. 2020; 125(6):600-603. PMC: 7227174. DOI: 10.1007/s11547-020-01217-8. View

Specht M, Sobti N, Rosado N, Tomczyk E, Abbate O, Ellis D . High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis. Breast Cancer Res Treat. 2020; 182(3):679-688. PMC: 7304917. DOI: 10.1007/s10549-020-05739-7. View

Shrikhande S, Pai P, Bhandare M, Bakshi G, Chaukar D, Chaturvedi P . Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care Policy. Ann Surg. 2020; 272(3):e249-e252. PMC: 7299113. DOI: 10.1097/SLA.0000000000004116. View

Paleri V, Hardman J, Tikka T, Bradley P, Pracy P, Kerawala C . Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration. Head Neck. 2020; 42(7):1674-1680. PMC: 7267183. DOI: 10.1002/hed.26219. View

Tasdoven I, Karadeniz Cakmak G . Breast cancer surgery under the shadow of COVID-19: Quest for optimal axillary management after neo-adjuvant chemotherapy. Breast J. 2020; 26(8):1606-1608. PMC: 7276864. DOI: 10.1111/tbj.13892. View

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View

Samiee S, Hadjilooei F, Alamolhoda M, Akhlaghpoor S . New Policy and Regulations for a Radiology-Oncology Center During the COVID-19 Outbreak in Tehran, Iran. Adv Radiat Oncol. 2020; 5(4):550-557. PMC: 7195356. DOI: 10.1016/j.adro.2020.04.005. View

10.

Chen W, Teckie S, Somerstein G, Adair N, Potters L . Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution. Adv Radiat Oncol. 2020; 5(4):621-627. PMC: 7212958. DOI: 10.1016/j.adro.2020.04.021. View

11.

Beddok A, Calugaru V, Minsat M, Dendale R, De Oliveira A, Costa E . Post-lockdown management of oncological priorities and postponed radiation therapy following the COVID-19 pandemic: Experience of the Institut Curie. Radiother Oncol. 2020; 150:12-14. PMC: 7274096. DOI: 10.1016/j.radonc.2020.05.043. View

12.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A . Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016; 5(1):210. PMC: 5139140. DOI: 10.1186/s13643-016-0384-4. View

13.

Chen Y, Hsu F, Tsai C, Cheng J . Efforts to Reduce the Impact of Coronavirus Disease 2019 Outbreak on Radiation Oncology in Taiwan. Adv Radiat Oncol. 2020; 5(4):534-537. PMC: 7195280. DOI: 10.1016/j.adro.2020.03.005. View

14.

de Marinis F, Attili I, Morganti S, Stati V, Spitaleri G, Gianoncelli L . Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model. Front Oncol. 2020; 10:665. PMC: 7188943. DOI: 10.3389/fonc.2020.00665. View

15.

Huang S, OSullivan B, Su J, Ringash J, Bratman S, Kim J . Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal. Cancer. 2020; 126(15):3426-3437. PMC: 7300809. DOI: 10.1002/cncr.32968. View

16.

Larrea L, Lopez E, Antonini P, Gonzalez V, Berenguer M, Banos M . COVID-19: hypofractionation in the Radiation Oncology Department during the 'state of alarm': first 100 patients in a private hospital in Spain. Ecancermedicalscience. 2020; 14:1052. PMC: 7289607. DOI: 10.3332/ecancer.2020.1052. View

17.

Cai Y, Wang W, Li C, Zeng D, Zhou Y, Sun R . Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital. Head Neck. 2020; 42(6):1153-1158. PMC: 7262070. DOI: 10.1002/hed.26161. View

18.

Sorrentino L, Guaglio M, Cosimelli M . Elective colorectal cancer surgery at the oncologic hub of Lombardy inside a pandemic COVID-19 area. J Surg Oncol. 2020; 122(2):117-119. PMC: 7300572. DOI: 10.1002/jso.26052. View

19.

Bongiovanni A, Mercatali L, Fausti V, Ibrahim T . Comment on 'Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey' by Alice Indini et al. Eur J Cancer. 2020; 134:3-5. PMC: 7229924. DOI: 10.1016/j.ejca.2020.04.047. View

20.

Gatfield E, Mukesh M, Loo S . Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits. Clin Oncol (R Coll Radiol). 2020; 32(10):e218. PMC: 7280104. DOI: 10.1016/j.clon.2020.06.001. View